• 11/10/2024

Germany’s Merck Bets on AI Drug-Design Pacts, Rules Out M&A

Wall Street Journal

Merck—known as EMD Group in the U.S.— is betting on artificial-intelligence partnerships to develop new drugs, but said it won’t bring in external expertise through acquisitions.

https://www.wsj.com/articles/germanys-merck-bets-on-ai-drug-design-partnerships-rules-out-acquisitions-interview-943c5b7a